Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Biglycan and decorin differentially regulate signaling in the fetal membranes.

Wu Z, Horgan CE, Carr O, Owens RT, Iozzo RV, Lechner BE.

Matrix Biol. 2014 Apr;35:266-75. doi: 10.1016/j.matbio.2013.12.006.

2.

A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.

Calmus ML, Macksoud EE, Tucker R, Iozzo RV, Lechner BE.

Reproduction. 2011 Jul;142(1):183-94. doi: 10.1530/REP-10-0387.

3.

Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.

de Miranda de Araujo LB, Horgan CE, Aron A, Iozzo RV, Lechner BE.

Mol Reprod Dev. 2015 May;82(5):387-96. doi: 10.1002/mrd.22488.

4.

Chorioamniontis in preterm delivery is associated with degradation of decorin and biglycan and depletion of hyaluronan in fetal membranes.

Meinert M, Malmström A, Petersen AC, Eriksen GV, Uldbjerg N.

Placenta. 2014 Aug;35(8):546-51. doi: 10.1016/j.placenta.2014.05.004.

PMID:
24920507
5.

Altered decorin and Smad expression in human fetal membranes in PPROM.

Horgan CE, Roumimper H, Tucker R, Lechner BE.

Biol Reprod. 2014 Nov;91(5):105. doi: 10.1095/biolreprod.114.121236.

6.

Uterine dysfunction in biglycan and decorin deficient mice leads to dystocia during parturition.

Wu Z, Aron AW, Macksoud EE, Iozzo RV, Hai CM, Lechner BE.

PLoS One. 2012;7(1):e29627. doi: 10.1371/journal.pone.0029627.

7.

Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.

Yamachika S, Brayer J, Oxford GE, Peck AB, Humphreys-Beher MG.

Clin Exp Rheumatol. 2000 Mar-Apr;18(2):233-40.

PMID:
10812497
8.

A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.

Nikolovska K, Renke JK, Jungmann O, Grobe K, Iozzo RV, Zamfir AD, Seidler DG.

Matrix Biol. 2014 Apr;35:91-102. doi: 10.1016/j.matbio.2014.01.003.

9.

The injury response of aged tendons in the absence of biglycan and decorin.

Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Kumar A, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ.

Matrix Biol. 2014 Apr;35:232-8. doi: 10.1016/j.matbio.2013.10.008.

10.

Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.

Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF.

J Bone Miner Res. 2002 Jul;17(7):1180-9.

11.

The tendon injury response is influenced by decorin and biglycan.

Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Satchell L, Kumar A, Pathmanathan L, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ.

Ann Biomed Eng. 2014 Mar;42(3):619-30. doi: 10.1007/s10439-013-0915-2.

12.

Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?

Marzoll A, Melchior-Becker A, Cipollone F, Fischer JW.

J Cell Mol Med. 2011 Feb;15(2):232-43. doi: 10.1111/j.1582-4934.2009.00986.x.

15.

Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.

Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E.

Matrix Biol. 2006 Aug;25(6):332-41.

PMID:
16766169
16.

Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice.

Zhang Y, Mori T, Iseki K, Hagino S, Takaki H, Takeuchi M, Hikake T, Tase C, Murakawa M, Yokoya S, Wanaka A.

Dev Dyn. 2003 Apr;226(4):618-26.

17.

Achilles tendons from decorin- and biglycan-null mouse models have inferior mechanical and structural properties predicted by an image-based empirical damage model.

Gordon JA, Freedman BR, Zuskov A, Iozzo RV, Birk DE, Soslowsky LJ.

J Biomech. 2015 Jul 16;48(10):2110-5. doi: 10.1016/j.jbiomech.2015.02.058.

18.

Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer.

Wu J, Utani A, Endo H, Shinkai H.

J Dermatol Sci. 2001 Oct;27(2):95-103.

PMID:
11532373
19.

Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.

Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG, Chen XD, Young MF.

J Biol Chem. 2005 Aug 26;280(34):30481-9.

20.

Decorin and biglycan expression: its relation with endothelial heterogeneity.

Calabrese GC, Gazzaniga S, Oberkersch R, Wainstok R.

Histol Histopathol. 2011 Apr;26(4):481-90. doi: 10.14670/HH-26.481.

PMID:
21360441

Supplemental Content

Support Center